--- title: "The State of Parkinson's Clinical Trials" description: "How many Parkinson's trials are recruiting right now, what stages they're in, what they're testing, who can join, and where they're running. Figures update daily from ClinicalTrials.gov." canonical_url: "https://parkinsonspathways.com/learn/state-of-parkinsons-clinical-trials" date_published: 2026-05-31 date_modified: 2026-06-01 source: "Parkinson's Pathways" --- # The State of Parkinson's Clinical Trials Parkinson's research moves fast. New trials open, others finish recruiting, and the mix of what's being tested shifts from month to month. This is a living overview of where things stand right now. The headline figures on this page update automatically every day from ClinicalTrials.gov, so it stays current rather than a snapshot frozen in time. For the full interactive dashboard, with charts and a map you can explore, see the [State of Parkinson's Research](/insights) page. This article walks through the same picture in plain language. ## How Many Trials Are Recruiting Right Now At any given time there are several hundred Parkinson's clinical trials actively recruiting participants, with new studies added every month. That pace is one of the more encouraging things about Parkinson's research. The list is not static; it grows and refreshes constantly, which is exactly why a one-time printout from any source goes stale quickly. If a trial doesn't fit today, a better one may open in a few weeks. For the live count, see the [research dashboard](/insights). ## What Stages the Research Is In Trials are grouped into phases that describe how far along a treatment is. Early-phase trials (Phase 1 and Phase 2) test safety and the first signs of whether something works. Phase 3 trials are the large, late-stage studies that determine whether a treatment reaches approval. A meaningful number of recruiting Parkinson's trials are in Phase 3, which means several treatments are in their final stretch of testing. If you want the full breakdown of what each phase means for you, our guide on [what clinical trial phases mean](/learn/what-do-clinical-trial-phases-mean) walks through it. ## What's Actually Being Tested Most Parkinson's trials are **interventional**, meaning participants receive an actual treatment or therapy. The rest are observational, where researchers monitor people over time without giving a new treatment. The difference matters for what your time commitment looks like, and we cover it in [interventional vs observational trials](/learn/interventional-vs-observational-parkinsons-trials). The single most common kind of intervention is a drug, but the field is broad: drugs, devices, surgical procedures, behavioral programs, and gene therapies are all being studied at once. That variety is good news, because it means the research isn't betting on a single approach. ## Who Can Participate Eligibility is broader than many families expect. Across recruiting trials, most are open to all genders and a large share have no upper age limit at all. In other words, being older is rarely a barrier on its own. Every trial still has its own specific criteria, and the only way to know if you qualify is to look at the details. Our [trial matching tool](/match) can narrow the list to the trials that fit your situation in about a minute. ## Where Trials Are Happening Parkinson's research is global. Recruiting trials are running across dozens of countries and hundreds of cities. For people willing and able to travel, that widens the options considerably; for everyone else, the number of local sites keeps growing as established trials add new locations. You can search by city or postcode on the [trials near me](/trials-near-me) page. ## Who's Running the Research Parkinson's trials are run by a mix of large pharmaceutical sponsors, academic medical centers, and smaller biotech companies. Who runs a trial affects how it is designed and who can join. Our piece on [industry-sponsored vs academic trials](/learn/industry-sponsored-vs-academic-parkinsons-trials) explains the difference. ## What This Means for You The big picture is genuinely hopeful. Hundreds of trials are recruiting, many are in their final stage of testing, eligibility is wider than most people assume, and the research spans the whole world. None of that guarantees a fit for any one person, but it does mean the odds of finding something worth a conversation with your neurologist are better than they have ever been. Browse the full interactive picture on the [State of Parkinson's Research dashboard](/insights), or jump straight to [recruiting trials](/trials). Both are updated daily. ## Frequently Asked Questions ### How many Parkinson's clinical trials are recruiting right now? Several hundred Parkinson's trials are actively recruiting at any given time, and new ones open every month. The exact count changes daily, so this article and the State of Parkinson's Research dashboard both pull the live figure directly from ClinicalTrials.gov. ### Are these numbers kept up to date? Yes. The headline figures on this page are pulled live from the same data that updates every 24 hours from ClinicalTrials.gov. This is a living article, not a once-a-year report, so the snapshot you see reflects the current state of recruiting Parkinson's research. ### Do I have to be a certain age to join a Parkinson's trial? Usually not. Most recruiting Parkinson's trials are open to a wide age range, and a large share have no upper age limit at all. Each trial sets its own criteria, so the only way to know for sure is to check the specific study or use the matching tool. ### Where can I see the full breakdown of Parkinson's trial statistics? The State of Parkinson's Research dashboard at /insights has the full interactive picture, including phase charts, study-type splits, eligibility stats, top sponsors, and a map of where trials are running. --- *Canonical: https://parkinsonspathways.com/learn/state-of-parkinsons-clinical-trials* *HTML version: https://parkinsonspathways.com/learn/state-of-parkinsons-clinical-trials*